• No results found

7. Confirm Response Message Type (MT-ACK-1)

7.3. MSA – Message Acknowledgement Segment

SEQ ELEMENT NAME LEN DATA

TYPE

Usage Cardinality Comment/

Description

1 Acknowledgment Code 2 ID R [1..1] 7.3.1

2 Message Control ID 20 ST R [1..1] 7.3.2

3 Text Message 80 ST X [0..0]

4 Expected Sequence Number 15 NM X [0..0]]

5 Delayed Acknowledgment Type 1 ID X [0..0]

6 Error Condition 250 CE X [0..0]

7.3.1. MSA-1 Acknowledgment code (ID)

HL7 Definition: This field contains the acknowledgment code, per the HL7 message processing rules.

Refer to HL7 Table 0008 - Acknowledgment code for valid values (Note: Table 0008 does not appear in Appendix B).

In this table, the value “CA” corresponds to “Enhanced mode: Accept acknowledgment: Commit Accept.” This value means that the receiving system has committed the message to safe storage in a manner that releases the sending system from the need to resend the message.

ELINCS Specification: In the Result Confirm Response interaction (IN-5), acknowledgement messages are intended to confirm specifically that a message has been received and committed to safe storage.

Hence, the value of MSA-1 Acknowledgement Code in the MT-ACK-1 message type should be hard coded to:

CA

7.3.2. MSA-2 Message control ID (ST)

HL7 Definition: This field contains the message control ID of the message sent by the sending system. It allows the sending system to associate this response with the message for which it is intended.

ELINCS Specification: Note that the combination of the values in MSA-2 Message Control ID and MSH-6 Receiving Facility should be unique to the recipient of the acknowledgement message (i.e., the Order Fulfiller).

Appendix A: Tests Requiring LOINC Coding in OBX Segment

The following table lists the test analytes that must be identified using LOINC codes3 in the ELINCS specification (i.e., in the OBX-3 Observation Identifier field). The tests comprise common laboratory tests and lab tests required to calculate HEDIS measures. These tests were selected because they (1) represent the top 80% of laboratory tests performed based on sample files provided by three sources in California, or (2) represent the tests that are most useful for quality-improvement programs related to HEDIS, and (3) represent a manageable set of tests to LOINC encode in a reasonable time.

The following defines each column in the tables of this appendix.

Test Category: A high-level grouping of tests. This is not intended to represent the constituents of common “panels” (such as CBC’s, basic metabolic or urinalysis panels), but simply to group tests editing and browsing purposes. Note that tests associated with HEDIS measures are explicitly identified.

Test: This is the common test name for specific analytes that should be mapped to LOINC codes.

Test Description: This gives more descriptive information regarding the test analytes and should be sufficient to identify the specific tests requiring LOINC coding.

LOINC Code(s): The LOINC codes that correspond to the named tests. Laboratories may also use the definitions of these tests as specified in the LOINC standard (see www.loinc.org) to identify the specific tests in their test masters that require LOINC coding. Analyses may have many LOINC codes referring to the same analyte. For example, the information in this column indicates that any tests with the LOINC code 4548-4, 4549-2, 17855-8, or 17856-6 qualifies as a hemoglobin A1c test.

Comparable CPT Code(s): This column shows the CPT codes that are specified at the level of test purpose or specific to the test. Note that the information in this field does not necessarily provide a one-to-one mapping from LOINC codes to CPT codes, or vice-versa. Some analytes (e.g., BANDS) do not have their own CPT codes, but may belong to panels (such as CBCs) that do have associated CPT codes.

Sample Values: This column simply shows some example values for the results of the indicated tests.

3

Logical Observation Identifiers Names and Codes (LOINC) is a standard, non-proprietary

coding system for laboratory tests and other clinical observations. LOINC codes uniquely

identify tests based on a combination of their features, including the analyte being measured,

the specimen being tested, and the test methodology being used. Over 25,000 LOINC codes

exist for laboratory tests. See www.loinc.org for additional information.

Test

Purpose Test Test Description LOINC Code(s)

Comparable BANDS Neutrophil bands, patient

blood, quantitative

1.14 K/uL BASOPHILS Basophils, patient blood

quantitative

0.1 K/uL BASOPHILS % Basophils as percent of total

leukocytes EOSINOPHILS Eosinophils, patient blood

quantitative

0.1 K/uL EOSINOPHILS % Eosinphils as percent of

total leukocytes

4%

LYMPHOCYTES Lymphocytes, patient blood quantitative

3.1 K/uL LYMPHOCYTES % Lymphocytes as percent of

total leukocytes

MCV Mean Corpuscular Volume,

patient RBC, quantitative

MONOCYTES Monocytes, patient blood quantitative

2.4 K/uL MONOCYTES % Monocytes as percent of

total leukocytes

3%

MPV Mean Platelet Volume,

patient blood quantitative

9.23 fL MYELOCYTE Myelocytes, patient blood

quantitative

1%

NEUTROPHILS Neutrophils, patient blood quantitative

1.5 K/uL NEUTROPHILS % Neutrophils as percent of

total leukocytes

53%

NUCLEATED RBC'S Neucleated Erythrocytes, patient blood quantitative

/100 WBC PLATELETS Platelets, patient blood

quantitative

RBC MORPHOLOGY Red Blood Cell

WBC White Blood Cells

(Leukocytes), patient blood

BUN/CREAT RATIO Urea Nitrogen/Creatinine ratio, patient serum/plasma, quantitative

13 GLOBULIN (CALC) Globulin (calculated),

patient urine quantitative EPITHELIAL Epithelial cells, patient

urine quantitative

URINE BILIRUBIN Bilirubin, patient urine quantitative

NEGATIVE URINE BLOOD Blood, patient urine

quantitative

MEDERATE,

1+

URINE COLOR Urine Color, nominal STRAW

URINE KETONE Ketones, patient urine quantative

NEGATIVE, 40

mg/dL URINE NITRITE Nitrite, patient urine

quantative

NEGATIVE

URINE PH PH, patient urine quantative 5.0

URINE, RBC RBC, patient urine quantitative URINE UROBILINOGEN Urobiligen, patient urine

quantative

0.2 EU/dL,

NORMAL URINE, WBC WBC, patient urine

quantitative

ALT Transferase; alanine amino, patient serum/ plasma, quantitative

84460

24 U/L

ALT/SGPT Alanine Amino Transferase:

Aspartate Amino BILIRUBIN, DIRECT Bilirubin direct, patient

serum/plasma, quantitative

82248

0.1 mg/dL BILIRUBIN, TOTAL Bilirubin total, patient

serum/plasma, quantitative

CALCIUM Calcium, total patient blood

quantitative

CHLORIDE Chloride, patient blood

quantitative

82435

99 mmol/L CHOL/HDL RATIO Total Cholesterol/HDL

Cholesterol ratio, patient serum/plasma quantitative

80061

3.2 CREATININE Creatinine, patient blood

quantitative

LDL/HDL RISK RATIO LDL Cholesterol/HDL Cholesterol ratio, patient serum/plasma quantitative

80061

3 OCCULT BLOOD Hemocult Blood, patient

stool, qualitative

POTASSIUM Potassium, patient serum

quantitative

84132

4.5 mmol/L PROTEIN, TOTAL Total Protein, patient serum

quantitative

RHEUMATOID FACTOR Rheumatoid factor, patient serum quantitative

TSH, SERUM Thyroid Stimulating Hormone, patient

serum/plasma quantitative

84443

1.51 mIU/L URINE GLUCOSE Glucose, patient urine

quantitative

Urine Albumin Albumin, patient urine quantitative Urine Protein Protein, patient urine

quantitative

LDL-Cholesterol LDL Cholesterol, patient serum/plasma quantitative HDL-Cholesterol HDL Cholesterol, patient

serum/plasma quantitative Total Cholesterol Total Cholesterol, patient

serum/plasma quantitative

14647-2, 2093-3,

32308-9

150 mg/dl

Triglycerides Triglycerides, patient

serum/plasma quantitative

HEDIS:

Colorectal Cancer Screening

Fecal Occult Blood Test Hemoglobin, patient stool nominal

Chlamydia Trachomatis

Culture

specimens include cervical swab, vaginal swab, and urine sediment

6349-5, 14463-4, 14464-2, 14467-5

Text Result

Chlamydia Trachomatis

Antigen Detection

specimens include cervical swab, vaginal swab, and urine sediment

Chlamydia Trachomatis

DNA Probe

Chlamydia Trachomatis

rRNA Probe

specimens include urine 4993-2, 16602-5

not available

Appendix B: Enumerated Value Tables

HL7 Table 0001 - Administrative sex

Value Description F Female M Male O Other

HL7 Table 0038 - Order status

Value Description

A Some, but not all, results available CA Order was canceled

CM Order is completed DC Order was discontinued ER Error, order not found HD Order is on hold

IP In process, unspecified RP Order has been replaced SC In process, scheduled

HL7 Table 0065 - Specimen action code

Value Description

A Add ordered tests to the existing specimen G Generated order; reflex order

L Lab obtained specimen from patient

O Specimen obtained by service other than Lab

HL7 Table 0070 - Specimen source codes

Value Description

ABS Abscess AMN Amniotic fluid

ASP Aspirate BPH Basophils BIFL Bile fluid BLDA Blood arterial

BBL Blood bag

BLDC Blood capillary BPU Blood product unit BLDV Blood venous

BON Bone

BRTH Breath (use EXHLD) BRO Bronchial BRN Burn

CALC Calculus (=Stone)

CDM Cardiac muscle

CNL Cannula

CTP Catheter tip

CSF Cerebral spinal fluid

CVM Cervical mucus

CVX Cervix COL Colostrum BLDCO Cord blood

CNJT Conjunctiva CUR Curettage CYST Cyst

DIAF Dialysis fluid DOSE Dose med or substance

DRN Drain

DUFL Duodenal fluid EAR Ear

Value Description EARW Ear wax (cerumen)

ELT Electrode ENDC Endocardium ENDM Endometrium EOS Eosinophils RBC Erythrocytes EYE Eye

EXG Exhaled gas (=breath) FIB Fibroblasts FLT Filter FIST Fistula

FLU Body fluid, unsp GAS Gas

GAST Gastric fluid/contents GEN Genital

GENC Genital cervix GENL Genital lochia GENV Genital vaginal

HAR Hair

IHG Inhaled Gas

IT Intubation tube

ISLT Isolate LAM Lamella WBC Leukocytes

LN Line LNA Line arterial

LNV Line venous

LIQ Liquid NOS

LYM Lymphocytes MAC Macrophages MAR Marrow MEC Meconium

Value Description MBLD Menstrual blood

MLK Milk MILK

NAIL Nail

NOS Nose (nasal passage) Other

PAFL Pancreatic fluid PAT Patient

PRT Peritoneal fluid /ascites PLC Placenta PLAS

PLB Plasma bag

PLR Pleural fluid (thoracentesis fld)

Polymorphonuclear neutrophils PPP Platelet poor plasma

PRP Platelet rich plasma PUS Pus

RT Route of medicine SAL

SMN Seminal fluid SER Serum

Skin

SKM Skeletal muscle SPRM Spermatozoa

SPT Sputum SPTC Sputum - coughed SPTT

STON Stone (use CALC) STL Stool = Fecal

Sweat

SNV Synovial fluid (Joint fluid) TEAR Tears

Breast milk

ORH

Plasma

PMN

Saliva

SKN

Sputum - tracheal aspirate

SWT

Value Description THRT Throat

THRB Thrombocyte (platelet) TISS Tissue

TISG Tissue gall bladder TLGI Tissue large intestine

TLNG Tissue lung

TISPL Tissue placenta TSMI Tissue small intestine TISU Tissue ulcer

TUB Tube NOS

ULC Ulcer

UMB Umbilical blood UMED Unknown medicine

URTH Urethra UR Urine URC Urine clean catch URT Urine catheter URNS Urine sediment USUB Unknown substance

VITF Vitreous Fluid VOM Vomitus

BLD Whole blood

BDY Whole body

WAT Water WICK Wick

WND Wound

WNDA Wound abscess

WNDE Wound exudate

WNDD Wound drainage

XXX To be specified in another part of the message

User-defined Table 0078 - Abnormal flags

Value Description L Below low normal H Above high normal LL Below lower panic limits HH Above upper panic limits

< Below absolute low-off instrument scale

> Above absolute high-off instrument scale N Normal (applies to non-numeric results) A Abnormal (applies to non-numeric results)

AA Very abnormal (applies to non-numeric units, analogous to panic limits for numeric units)

U Significant change up D Significant change down

B Better--use when direction not relevant W Worse--use when direction not relevant

S Susceptible. Indicates for microbiology susceptibilities only.

R Resistant. Indicates for microbiology susceptibilities only.

I Intermediate. Indicates for microbiology susceptibilities only.

MS Moderately susceptible. Indicates for microbiology susceptibilities only.

VS Very susceptible. Indicates for microbiology susceptibilities only.

HL7 Table 0085 - Observation result status codes interpretation

Value Description

C Record coming over is a correction and thus replaces a final result D Deletes the OBX record

F Final results; Can only be changed with a corrected result.

P Preliminary results

X Results cannot be obtained for this observation

U Results status change to final without retransmitting results already sent as

‘preliminary.’ E.g., radiology changes status from preliminary to final W Post original as wrong, e.g., transmitted for wrong patient

HL7 Table 0123 - Result status for OBR segment

Value Description

O Order received; specimen not yet received

I No results available; specimen received, procedure incomplete S No results available; procedure scheduled, but not done A Some, but not all, results available

P Preliminary: A verified early result is available, final results not yet obtained C Correction to results

R Results stored; not yet verified

F Final results; results stored and verified. Can only be changed with a corrected result.

X No results available; Order canceled.

Y No order on record for this test. (Used only on queries) Z No record of this patient. (Used only on queries)

HL7 Table 0125 - Value type

Value Description

AD Address CE Coded Entry

CF Coded Element With Formatted Values CK Composite ID With Check Digit

CN Composite ID And Name

Value Description CP Composite Price

CX Extended Composite ID With Check Digit DT Date

ED Encapsulated Data FT Formatted Text (Display) MO Money

NM Numeric PN Person Name RP Reference Pointer SN Structured Numeric ST String Data.

TM Time

TN Telephone Number TS Time Stamp (Date & Time) TX Text Data (Display) XAD Extended Address

XCN Extended Composite Name And Number For Persons XON Extended Composite Name And Number For Organizations XPN Extended Person Name

XTN Extended Telecommunications Number

HL7 Table 0155 - Accept/application acknowledgment conditions

Value Description

AL Always NE Never

ER Error/reject conditions only SU Successful completion only

HL7 Table 0190 – Address Type

Value Description

B Firm/Business

BA Bad address

BDL Birth delivery location (address where birth occurred) BR Residence at birth (home address at time of birth) C Current Or Temporary

F Country Of Origin H Home

L Legal Address

M Mailing

N Birth (nee) (birth address, not otherwise specified) O Office

P Permanent

RH Registry home. Refers to the information system, typically managed by a public health agency, that stores patient information such as immunization histories or cancer data, regardless of where the patient obtains services.

HL7 Table 0200 - Name type

Value Description

A Alias Name

B Name at Birth

C Adopted Name

D Display Name

I Licensing Name

L Legal Name

M Maiden Name

N Nickname /"Call me" Name/Street Name

P Name of Partner/Spouse (retained for backward compatibility only) R Registered Name (animals only)

S Coded Pseudo-Name to ensure anonymity T Indigenous/Tribal/Community Name U Unspecified

HL7 Table 0203 - Identifier type

Value Description

AM American Express

AN Account number BA Bank Account Number BR Birth registry number BRN Breed Registry Number DI Diner’s Club card DL Driver’s license number

DN Doctor number

DR Donor Registration Number

DS Discover Card

EI Employee number

EN Employer number

FI Facility ID

GI Guarantor internal identifier GN Guarantor external identifier HC Health Card Number

JHN Jurisdictional health number (Canada)

LN License number

LR Local Registry ID

MA Medicaid number

MC Medicare number

MCN Microchip Number

MR Medical record number MS MasterCard NE National employer identifier NH National Health Plan Identifier NI National unique individual identifier

NNxxx National Person Identifier where the xxx is the ISO table 3166 3-character (alphabetic) country code

NPI National provider identifier

PEN Pension Number

PI Patient internal identifier

Value Description

PN Person number

PRN Provider number

PT Patient external identifier RR Railroad Retirement number RRI Regional registry ID

SL State license

SR State registry ID

SS Social Security number U Unspecified

UPIN Medicare/HCFA’s Universal Physician Identification numbers

VN Visit number

VS VISA

WC WIC identifier

WCN Workers’ Comp Number

XX Organization identifier

User Defined Table 0396 – Coding Systems

Value Description

L Local general code C4 CPT-4

HPC HCFA Procedure Codes (HCPCS) I10P ICD-10 Procedure Codes

I9C ICD-9CM

LN Logical Observation Identifier Names and Codes (LOINC(r)) SNM Systemized Nomenclature of Medicine (SNOMED)

SCT Snomed CT

User Defined Table 0362 – Sending/Receiving Facility

Value Description

CL CLIA ID assigned per the Clinical Laboratory Improvement Act

CP CLIP ID issued for DoD laboratories by Armed Forces Institute of Pathology

Appendix C. Summary View of Result Message Types

The following tables summarize the message structure and message segments for the three types of result message: Result Status (MT-ORU-1), Result Available (MT-ORU-2), and Result Correction (MT-ORU-3). Although Section 6 includes more detail about each field in the included segments, the representation below is more specific to each message type and more informative when implementing and conformance testing each message type. Note that the

“Comment/Description” column in the Attribute Tables references the description of each field

as it applies to the indicated message type (for example, see MSH-21 Conformance Statement

ID).

Related documents